Previous 10 | Next 10 |
Chinese Officials Confirm China Won't Restrict Exports of Medical Products Needed to Fight Coronavirus Company in Late-Stage Negotiations to Secure Distribution Agreement for Additional COVID-19 IgG/IgM Rapid Test Which is Approved by China's National Medical Products Administration (NM...
ANI Pharmaceuticals Submit Application for Relaunching Cortrophin Gel ANI Pharmaceuticals Inc. ( ANIP ) announced that it has submitted a Prior Approval Supplement to the FDA. The supplement has been filed with the Endocrinology Division of the regulatory body. The application pertains to ...
Aytu BioScience ( AYTU -1.6% ) announces that results from an independent clinical study using its licensed COVID-19 IgG/IgM Rapid Test were published in the journal Infection Ecology & Epidemiology, further validating the accuracy, specificity and performance of the antibody ra...
Independent clinical study demonstrates test accuracy of 98.0% and 94.1% for IgG and IgM, respectively, when using PCR-positive cases as true positives ENGLEWOOD, CO / ACCESSWIRE / April 16, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), (the "Company"), a specialty pharmaceutical company ...
Applied DNA Sciences (NASDAQ: APDN ) +61% on advancement of COVID-19 vaccine candidates. More news on: Applied DNA Sciences, Inc., Comstock Holding Companies, Inc., BOQI International Medical Inc., Stocks on the move, , Read more ...
Company Places Third Purchase Order for One Million Tests ENGLEWOOD, CO / ACCESSWIRE / April 15, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs today provided an update on th...
If you’re like most people considering penny stocks to buy right now , you’re looking at certain criteria. A few things I would focus on include recent news, government approvals, financings, disclosure filings, and last but not least, technical indicators. Penny stocks are well...
Aytu BioScience ( AYTU -5.2% ) announces the launch of Regoxidine, an over-the-counter foam formulation of minoxidil available for use by both men and women. More news on: Aytu BioScience, Inc., Healthcare stocks news, Read more ...
ENGLEWOOD, CO / ACCESSWIRE / April 13, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs announced today the launch of Regoxidine®, an over-the-counter foam formulation of minox...
ENGLEWOOD, CO / ACCESSWIRE / April 9, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU) (the "Company"), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs announced that, due to Colorado's "shelter in place" order related to the Coro...
News, Short Squeeze, Breakout and More Instantly...
Company receives proceeds of $3.5 million through exercise of warrants, a portion of which was used to pay down debt Interest rate on new $13.0 million term loan reduced by approximately 350 basis points today, potentially saving the Company $1.3 million over the life of the term loan T...
Phoenix, Arizona and New York, New York--(Newsfile Corp. - May 29, 2024) - Lytham Partners, a leading investor relations and corporate access firm, today announced the schedule for its Spring 2024 Investor Conference taking place virtually on May 30, 2024. More than 40 companies will be available...
DENVER, CO / ACCESSWIRE / May 23, 2024 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced that Josh Disbrow, CEO, will participate in a webcasted fireside chat and host one-on-one meetings with inv...